Structural polymorphism in the promoter of pfmrp2 confers Plasmodium falciparum tolerance to quinoline drugs

Drug resistance in Plasmodium falciparum remains a challenge for the malaria eradication programmes around the world. With the emergence of artemisinin resistance, the efficacy of the partner drugs in the artemisinin combination therapies (ACT) that include quinoline-based drugs is becoming critical...

Descripción completa

Detalles Bibliográficos
Autores principales: Mok, Sachel, Liong, Kek-Yee, Lim, Eng-How, Huang, Ximei, Zhu, Lei, Preiser, Peter Rainer, Bozdech, Zbynek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286016/
https://www.ncbi.nlm.nih.gov/pubmed/24372851
http://dx.doi.org/10.1111/mmi.12505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286016/
https://www.ncbi.nlm.nih.gov/pubmed/24372851
http://dx.doi.org/10.1111/mmi.12505

Ejemplares similares